Psyence Biomedical (PBM) has released an update.
Psyence Biomedical Ltd. has issued a Senior Secured Convertible Note due June 14, 2027, with an original principal amount of $156,250 against a loan amount of $125,000. These securities have not been registered with the SEC and are subject to Canadian securities legislation trade restrictions. The terms include provisions for conversion, adjustment of the conversion price, and specific events that may affect the note’s terms, such as a Bankruptcy Event or Change of Control Transaction.
For further insights into PBM stock, check out TipRanks’ Stock Analysis page.
